Before you sell to, join or invest in Vesicor Therapeutics, Inc.
MentionFox check on Vesicor Therapeutics, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/vesicor-therapeutics-inc-form-d-25000001
Check Vesicor Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Vesicor Therapeutics, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Vesicor Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-05-14.
Vesicor Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on May 14, 2025. The filing reports $515K sold. Its industry group is Biotechnology. It names Luo Feng (Executive Officer, Director), Warren Hosseinion (Director), Oded Levy (Director) (SEC Form D, May 14, 2025).
Is this your company?
Sell to companies like Vesicor Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Vesicor Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Vesicor Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in May 2025, largest first.
Get an email when Vesicor Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Vesicor Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Vesicor Therapeutics, Inc. →Get the full cited report on Vesicor Therapeutics, Inc.
What the filing shows about Vesicor Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Vesicor Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Vesicor Therapeutics, Inc.'s address as 207 S. Santa Anita Street, Suite P-15, San Gabriel, CA 91776.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Vesicor Therapeutics, Inc. See pricing
Vesicor Therapeutics, Inc. is a registered filer with the SEC (CIK 1993074) and has filed since 2023-09-14. 2 filings are on record, the latest on 2025-05-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Vesicor Therapeutics, Inc.'s Form D of 2025-05-14 names Luo Feng, Warren Hosseinion, Oded Levy and 2 more as its officers, directors or promoters.
Its new offerings report $715K sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Luo Feng is named as Executive Officer and Director on the Form D that Vesicor Therapeutics, Inc. filed with the SEC on 14 May 2025, one of 5 people that filing names.
Warren Hosseinion is named as Director on the Form D that Vesicor Therapeutics, Inc. filed with the SEC on 14 May 2025, one of 5 people that filing names.
Oded Levy is named as Director on the Form D that Vesicor Therapeutics, Inc. filed with the SEC on 14 May 2025, one of 5 people that filing names.
Michael Bowen is named as Executive Officer on the Form D that Vesicor Therapeutics, Inc. filed with the SEC on 14 May 2025, one of 5 people that filing names.
Warren Jr. Hosseinion is named as Executive Officer on the Form D that Vesicor Therapeutics, Inc. filed with the SEC on 14 May 2025, one of 5 people that filing names.
5 people named on the filing — 3 holding an executive role and 2 as directors only.
Named as of the 2025-05-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Vesicor Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Vesicor Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Vesicor Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Vesicor Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Vesicor Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-04 (vesicor.com).
Each opens in a new tab, filled in for Vesicor Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/vesicor-therapeutics-inc-form-d-25000001